![]() |
|
People
As director of the MBMC, Dr. Lawton is responsible for overseeing the coordination and completion of process development client services including expression development, fermentation and cell culture development, downstream processing, process optimization and characterization. Dr. Lawton works closely with companies on the verge of biopharmaceutical production to give them the opportunity to utilize the Center’s services to economically address staffing needs and learning curve constraints and to optimize time to market.
Dr. Lawton creates and teaches customized training programs for biopharmaceutical manufacturing workforce as well as advising and teaching undergraduate and graduate students in the fields of chemical and biochemical engineering and other fields. He also is responsible for developing and maintaining an applied research program which focuses on technological advances to improve the quality, cost and productivity of large-scale biomanufacturing production.
Before joining UMass Lowell and creating the MBMC, Dr. Lawton was a bioengineering process consultant to companies on both the east and west US coasts and in Canada.
Robert D. Lynch, Ph.D.
Before joining UMass Lowell, Dr. Lynch received his M.S. and Sc.D in nutrition from Harvard University’s School of Public Health Jin Xu, Ph.D.
Before joining UMass Lowell, Dr. Xu received his Ph.D in Biochemistry from the University of North Texas. Afterwards he worked as senior research scientist and principal scientist at Wyeth Pharmaceuticals for over five years, before most recently establishing and leading the protein chemistry group at Percivia, LLC.
Donato B. Vespa, Ph.D.
Before working with Dr. Lawton, Don worked for over five years with the Center for Chronic Disease Control performing in vivo and in vitro studies of drug substances and creating standard operating procedures (SOPs) for chemical analysis at the Center.
| |
|
|
|